Women suffering from multiple sclerosis complaining of lack or absence of sexual desire. Hypoactive sexual desire disorder
Conditions
Interventions
Intervention 1: Intervention group: Women suffering from multiple sclerosis with complaints of lack or absence of sexual desire use 500 mg capsules containing carrot seed powder 3 times a day for 12 w
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Married women with multiple sclerosis Age between 18-45 With complaints of lack or absence of sexual desire More than 6 months have passed since their marriage Normal pelvic examination findings Have a normal pap smear in the last 3 years Have access to having sex with a partner monthly for at least 15 days
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding Menopause Any disability or serious medical problem that requires constant care and treatment Suffering from major depressive disorder and other psychiatric disorders Husband's sexual problems Divorce
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall score of the FSFI questionnaire. Timepoint: At the beginning of the study and then every 4 weeks until week 12. Method of measurement: FSFI Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue rate. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: MFIS fatigue assessment questionnaire.;The level of anxiety and depression. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Spielberger anxiety questionnaire.;LH levels. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Laboratory kit.;FSH levels. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Laboratory kit.;Prolactin levels. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Laboratory kit.;Testosterone levels. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Laboratory kit.;CBC diff levels. Timepoint: At the beginning of the study and after 6 and 12 weeks of treatment. Method of measurement: Laboratory kit.;Interleukin-6 levels. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Laboratory kit.;TNF-a levels. Timepoint: At the beginning of the study and after 12 weeks of treatment. Method of measurement: Laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Vahid Reza Askari
Mashhad University of Medical Sciences
Outcome results
None listed